Skip to Content

Deltex Medical Group PLC DTXMF

Morningstar Rating
$0.00 0.00 (130.77%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

DTXMF is trading at a 632% premium.
Price
$0.00
Fair Value
$8.72
Uncertainty
Extreme
1-Star Price
$6.89
5-Star Price
$2.14
Economic Moat
Bbdz
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if DTXMF is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.00
Day Range
$0.000.00
52-Week Range
$0.000.99
Bid/Ask
$0.00 / $0.79
Market Cap
$5.69 Mil
Volume/Avg
10,000 / 32,500

Key Statistics

Price/Earnings (Normalized)
Price/Sales
1.60
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Deltex Medical Group PLC is a British manufacturer of Fluid Management devices, which include the ODM and now ODM+ haemodynamic monitoring systems. The company has developed the gold standard for haemodynamic monitoring with oesophageal Doppler technology, which is marketed as TrueVue Doppler and often generically referred to by clinicians as ODM. The company's initial and principal technology is Doppler-based ultrasound oesophageal haemodynamic monitoring.
Sector
Healthcare
Industry
Medical Devices
Stock Style Box
Small Value
Total Number of Employees
35

Valuation

Metric
DTXMF
Price/Earnings (Normalized)
Price/Book Value
1.36
Price/Sales
1.60
Price/Cash Flow
Price/Earnings
DTXMF

Financial Strength

Metric
DTXMF
Quick Ratio
1.04
Current Ratio
1.89
Interest Coverage
−4.57
Quick Ratio
DTXMF

Profitability

Metric
DTXMF
Return on Assets (Normalized)
−14.22%
Return on Equity (Normalized)
−34.60%
Return on Invested Capital (Normalized)
−13.52%
Return on Assets
DTXMF
See how this stock stacks up to its competitors with Morningstar Investor

Medical Devices Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
ABT
Abbott LaboratoriesPnwvlcnsVvynvh$180.8 Bil
SYK
Stryker CorpHpjcdxxxfFqkch$127.8 Bil
BSX
Boston Scientific CorpPygcwrpZdzpm$111.2 Bil
MDT
Medtronic PLCSzqsmrrvcSwrzrgk$107.9 Bil
EW
Edwards Lifesciences CorpYbjygcsjHvhxyn$53.0 Bil
DXCM
DexCom IncLrngyddnqsKxt$50.4 Bil
PHG
Koninklijke Philips NV ADRRtvqmrlvRxkpgz$25.4 Bil
ZBH
Zimmer Biomet Holdings IncYdtwhbmbrYggz$23.9 Bil
ALGN
Align Technology IncWbjbbydglRzjkxz$19.2 Bil
PODD
Insulet CorpQvhnmwykzVmyzblx$12.6 Bil

Sponsor Center